GUIDED THERAPEUTICS, INC. (GTHP) Total liabilities 2016–2025
GUIDED THERAPEUTICS, INC. (GTHP) total liabilities at each fiscal year-end, per SEC filings.
$7.3MFY2025 · since FY2016: $10.8M → $7.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.3M | +17.0% |
| FY2024 | $6.3M | +14.5% |
| FY2023 | $5.5M | -12.4% |
| FY2022 | $6.2M | -16.5% |
| FY2021 | $7.5M | -38.7% |
| FY2020 | $12.2M | -32.6% |
| FY2019 | $18.1M | +12.8% |
| FY2018 | $16.1M | -18.9% |
| FY2017 | $19.8M | +84.1% |
| FY2016 | $10.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More GTHP financial trends
GTHP RevenueGTHP Net incomeGTHP Net marginGTHP Gross profitGTHP Gross marginGTHP Operating incomeGTHP Operating marginGTHP Operating cash flowGTHP Free cash flowGTHP Capital expendituresGTHP Return on equityGTHP Stock buybacksGTHP Dividends paidGTHP Total assetsGTHP Shareholders’ equityGTHP overview →